Franklin K B, Herberg L J
Eur J Pharmacol. 1977 May 1;43(1):33-8. doi: 10.1016/0014-2999(77)90157-1.
Depression of self-stimulation by clonidine has been ascribed to continuous direct stimulation of alpha-adrenoceptors with consequent disruption of reinforcement signals thought to be conveyed by noradrenergic pathways. This suggestion was tested by administration of alpha-receptor blocking agents (piperoxane, phentolamine and phenoxybenzamine, PBZ) differing in their affinity for pre- and post-synaptic receptor sites. Piperoxane in low doses (0.55-5.0 mg/kg) previously reported to cause specific blockade of pre-synaptic receptors implicated in negative feedback circuits, caused a significant increase in self-stimulation rate and strongly antagonized the depression of self-stimulation by clonidine (0.15 mg/kg). A larger dose of piperoxane (45 mg/kg) and graded doses of phentolamine and PBZ, affecting both pre- and post-synaptic receptors, depressed self-stimulation, and did not antagonize clonidine-induced depression of self-stimulation. It is concluded that depression of self-stimulation by clonidine may depend on clonidine-induced inhibition of NA release exerted via presynaptic receptors, and that the effect of clonidine is not necessarily evidence that noncontingent adrenergic stimulation disrupts reinforcement.
可乐定对自我刺激的抑制作用被归因于对α-肾上腺素能受体的持续直接刺激,进而破坏了被认为由去甲肾上腺素能通路传递的强化信号。通过给予对突触前和突触后受体位点亲和力不同的α-受体阻断剂(哌罗克生、酚妥拉明和酚苄明,PBZ)来验证这一观点。低剂量(0.55 - 5.0毫克/千克)的哌罗克生先前报道可特异性阻断参与负反馈回路的突触前受体,导致自我刺激率显著增加,并强烈拮抗可乐定(0.15毫克/千克)对自我刺激的抑制作用。更大剂量的哌罗克生(45毫克/千克)以及影响突触前和突触后受体的不同剂量的酚妥拉明和PBZ,均会抑制自我刺激,且不能拮抗可乐定诱导的自我刺激抑制作用。得出的结论是,可乐定对自我刺激的抑制作用可能取决于可乐定通过突触前受体诱导的去甲肾上腺素释放的抑制,并且可乐定的作用不一定证明非条件性肾上腺素能刺激会破坏强化作用。